Healthcare -
Biotechnology - NASDAQ - US
$ 19.6
1.34 %
$ 3.27 B
Market Cap
14.41
P/E
ACAD - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ACAD - ACADIA Pharmaceuticals Inc.
25.1 M
LAST VALUE
17.63%
2 YEAR CAGR
-39.37%
5 YEAR CAGR
-13.86%
10 YEAR CAGR